Scribeable vs Suki:
Scribeable offers superior ambient documentation with comprehensive billing optimization, transparent pricing, and seamless web + mobile access — all built by clinicians.
Why Physicians Switch from Suki
Voice-command paradigm requires memorizing commands — not true ambient listening
Enterprise pricing with no published rates or self-service signup
Limited note type variety compared to full ambient scribe solutions
Head-to-Head Comparison
Ambient Listening vs. Voice Commands
Suki started as a voice assistant — you speak commands to fill in note fields. While they've added ambient features, the core paradigm is different from Scribeable's fully ambient approach. With Scribeable, you simply have a natural conversation with your patient and a complete note appears. No commands to memorize, no structured dictation, no workflow interruption. True ambient documentation means you focus on the patient, not the software.
Billing Intelligence Built In
Suki focuses on documentation speed, but leaves revenue on the table. Scribeable analyzes every encounter for ICD-10 codes, HCC/RAF opportunities, and appropriate E&M levels. Physicians who switch from Suki consistently find they were under-coding visits — missing $30-50 per encounter that adds up to tens of thousands annually. Documentation should pay for itself.
Accessible to Every Practice Size
Suki's enterprise model means custom pricing, sales conversations, and procurement processes. Scribeable publishes every price, offers a free tier with 15 notes per month, and lets you upgrade to Pro at $89/month with a single tap. Whether you're a solo family physician or a 50-provider group, you get the same powerful tool at the same published price.
Rounding Mode: A Feature No Other Scribe Offers
Hospitalists and rounding physicians see the most patients per day — and they're exactly the users who need multi-patient documentation the most. Scribeable's Rounding Mode lets you record an entire round in one session and generates individual notes for every patient. Suki requires you to start and stop for each encounter. For physicians who round daily, this single feature can save 30+ minutes and eliminate the documentation backlog that builds up by afternoon.
Same Patient. Same Encounter.
See why physicians say Scribeable notes are “actually usable” — with integrated risk scores, billing codes, and clinical reasoning that typical AI scribes simply don’t generate.
HPI
62 y/o male presents with chest pain for 2 hours. Substernal, pressure-like, radiating to left arm. Associated with diaphoresis and shortness of breath. Pain started while climbing stairs. Patient has history of HTN, DM2, and hyperlipidemia. Takes lisinopril, metformin, and atorvastatin. Denies recent illness or trauma.
Assessment & Plan
*Note examples are illustrative representations based on common AI documentation patterns. “Typical AI Scribe” represents composite characteristics of standard tools and does not depict any specific product. Patient scenarios are entirely fictional. Clinical notes should always be reviewed by a licensed provider.
AI Medical Scribe Note Quality Comparison
Scribeable produces clinically enriched notes with integrated risk calculators (HEART Score, CHA₂DS₂-VASc, Wells PE, PHQ-9, Caprini VTE), automated billing code optimization (E&M levels, HCC/RAF capture, CPT codes), dangerous diagnosis exclusion documentation, evidence-based prescribing citations, CMS compliance for operative reports, HEDIS care gap tracking, and MIPS quality measure documentation. Typical AI scribes produce basic notes without these advanced clinical features.
ED Chest Pain: 62-year-old male presenting with substernal chest pressure, diaphoresis, and exertional dyspnea
HPI: 62 y/o male presents with 2 hours of substernal chest pressure, rated 8/10, radiating to left arm and jaw. Onset during exertion (climbing stairs). Associated with diaphoresis and exertional dyspnea. Pressure-like quality, unrelieved by rest. No pleuritic component, no positional variation, no reproducibility with palpation. Risk factors: HTN (10 years), DM2 (8 years), hyperlipidemia, 30-pack-year smoking history (quit 5 years ago), family history of MI (father at age 58). Current medications: lisinopril 20mg daily, metformin 1000mg BID, atorvastatin 40mg daily. Denies cocaine use, recent immobilization, or prior VTE.
Assessment & Plan: 1. Acute Chest Pain — High-risk presentation HEART Score: 7 (High Risk) - History: moderately suspicious (2), EKG: non-specific ST changes (1), Age: >65 (2), Risk factors: ≥3 (2), Troponin: pending initial (0) - Risk stratification: >12% 6-week MACE event rate → full ACS workup - Serial troponins q3h, 12-lead EKG (initial + repeat at 60 min) - ASA 325mg PO administered, heparin drip per ACS protocol - Cardiology consulted for probable cath lab activation Dangerous Diagnosis Exclusion: - STEMI: No ST elevation on initial EKG — serial monitoring - Aortic dissection: No tearing quality, no pulse differential, no mediastinal widening on CXR - PE: Low pretest probability (Wells PE: 1.5) — no immobilization, no prior VTE, no hemoptysis 2. Hypertension — BP 168/94 on arrival, improved to 142/88 post-NTG - Continue home lisinopril, recheck prior to disposition 3. DM2 — Glucose 186 on arrival - Hold metformin (contrast exposure risk), sliding scale insulin PRN
Cardiology Consult: 71-year-old female with new-onset atrial fibrillation and decompensated heart failure
HPI: 71 y/o female with known HFrEF (EF 35% on TTE 6 months ago), HTN, DM2, and CKD Stage 3a (baseline Cr 1.4), consulted for new-onset atrial fibrillation with RVR. Progressive exertional dyspnea (NYHA II → IV over 2 weeks), 3-pillow orthopnea (new), PND, and 4+ pitting edema to knees bilaterally. Weight gain of 8 lbs over 2 weeks. Triggers explored: dietary indiscretion (holiday meals), medication non-adherence (ran out of furosemide 10 days ago). No prior AF history, no palpitations previously. Denies chest pain, syncope, or presyncope.
Assessment & Plan: Reason for Consult: New-onset atrial fibrillation with RVR in setting of acute decompensated HFrEF. Requesting Service: Internal Medicine (Dr. Patel) 1. New-onset Atrial Fibrillation with RVR CHA₂DS₂-VASc Score: 5 (Female sex, age ≥75, HTN, DM, HF) - Stroke risk: 6.7%/year → strong anticoagulation indication - Rate control: avoid diltiazem (negative inotropy in HFrEF) → amiodarone 150mg IV bolus then 1mg/min × 6h - Anticoagulation: apixaban 5mg BID (preferred over warfarin given age + fall risk) - TEE prior to any cardioversion attempt if AF duration uncertain - HAS-BLED: 2 (HTN, age) — acceptable bleeding risk 2. Acute Decompensated Heart Failure (ADHF) NYHA Functional Class: IV (dyspnea at rest) - IV furosemide 80mg BID (2.5× home oral dose), net negative 1-1.5L/day - Carvedilol held (acute decompensation), restart when euvolemic - Add sacubitril/valsartan when stable (PARADIGM-HF indication: EF ≤40% on ACEi) - BNP trend: 1,840 → monitor for response to diuresis 3. CKD Stage 3a — Cr 1.4 (baseline), monitor with aggressive diuresis - KDIGO risk: moderate — monitor Cr/K daily with diuresis
Operative Note: Right total knee arthroplasty in 68-year-old male with severe tricompartmental osteoarthritis
Operative Note: Preoperative Diagnosis: Right knee severe tricompartmental osteoarthritis (Kellgren-Lawrence Grade IV) Postoperative Diagnosis: Same Procedure: Right total knee arthroplasty Surgeon: Dr. James Morrison (attending — present and scrubbed for entire case) Assistant: Dr. Chen (PGY-4) Anesthesia: Spinal with sedation (Dr. Rivera) Implants: Smith & Nephew Legion CR, Size 5 femoral / Size 4 tibial / 10mm poly insert EBL: 150 mL Tourniquet Time: 62 minutes (pneumatic, 275 mmHg) Specimens: Femoral and tibial bone cuts — to pathology Complications: None Findings: Severe tricompartmental degenerative changes with exposed subchondral bone medially, grade III chondromalacia laterally, intact PCL
Post-Operative Plan: 1. Weight Bearing: WBAT right LE with front-wheeled walker 2. DVT Prophylaxis: Enoxaparin 40mg SQ daily × 14 days + mechanical (SCDs while inpatient) 3. Pain: Multimodal — scheduled acetaminophen 1g Q6h, meloxicam 15mg daily, tramadol 50mg Q6h PRN (max 14 days) 4. Antibiotics: Ancef 2g IV × 24h post-op 5. PT: Initiate POD0 PM — CPM machine, active/passive ROM, gait training 6. Follow-up: 2 weeks (staple removal + wound check), 6 weeks (X-ray + ROM assessment) 7. VTE Risk: Caprini Score 7 (High Risk) — extended pharmacologic prophylaxis indicated
Primary Care: 55-year-old female Medicare Advantage patient with DM2, HTN, depression, and overdue preventive care
HPI: 55 y/o female Medicare Advantage patient presenting for chronic disease management follow-up. Last visit 3 months ago. Diabetes (DM2, 8 years): A1c 8.2% (up from 7.6%), reports adherence but dietary indiscretion during holidays. Home glucose logs show fasting 140-180 range. No hypoglycemic episodes. Denies polyuria, polydipsia, vision changes, or foot numbness. Last diabetic eye exam: 14 months ago (overdue). Last podiatry visit: never. Hypertension (12 years): Home BP readings averaging 135-145/85-90. Taking lisinopril 20mg daily consistently. Depression (MDD, recurrent): PHQ-9 score today: 14 (moderately severe). Persistent low mood, anhedonia, poor sleep (initial insomnia), decreased concentration. On sertraline 50mg × 6 months with partial response. Denies SI/HI, denies alcohol or substance use. Columbia Suicide Severity: negative for ideation and behavior.
Assessment & Plan: 1. DM2, Uncontrolled (A1c 8.2%) — HCC 19 - Add empagliflozin 10mg daily (SGLT2i — CV and renal benefit, EMPA-REG OUTCOME indication) - Continue metformin 500mg BID (not escalating given GI intolerance history) - Diabetic eye exam referral (overdue 2 months — HEDIS measure) - Podiatry referral for initial foot exam - Recheck A1c in 3 months, target <7% 2. Hypertension, Suboptimally Controlled — HCC (when with CKD/DM) - BP today 138/86 — above target of <130/80 (ACC/AHA for DM patients) - Increase lisinopril to 40mg daily - Home BP log review in 4 weeks 3. Major Depressive Disorder, Recurrent, Moderate — HCC 59 - PHQ-9: 14 (moderately severe) — partial response to sertraline 50mg - Increase sertraline to 100mg daily - Safety plan reviewed, crisis line provided (988) - Follow-up in 4 weeks, recheck PHQ-9 - If inadequate response → consider augmentation or psychiatry referral 4. Preventive Care Gaps Addressed: - Mammogram ordered (last: 26 months ago — HEDIS BCS measure) - Colonoscopy referral (age 55, average risk, never screened — HEDIS COL) - Tobacco screening: former smoker, quit 3 years — MIPS measure 226 - Annual flu vaccine administered today — MIPS measure 110
Feature-by-Feature Comparison
Documentation
| Feature | Scribeable | Suki |
|---|---|---|
| Ambient recording | ||
| Voice commands | ||
| AI note generation | ||
| Multiple note types | ||
| Multi-patient rounding modeRecord entire rounds, get all notes at once |
EHR Integration
| Feature | Scribeable | Suki |
|---|---|---|
| Epic integration | ||
| Cerner integration | ||
| EHR navigation | ||
| Browser extension |
Billing
| Feature | Scribeable | Suki |
|---|---|---|
| ICD-10 suggestions | ||
| HCC code capture | ||
| E&M optimization |
Access
| Feature | Scribeable | Suki |
|---|---|---|
| Free tier | ||
| Solo practitioner plans | ||
| Transparent pricing |
*Feature comparisons reflect publicly available information as of February 2026. Competitor capabilities may change. Revenue figures represent potential outcomes reported by select users and are not guaranteed. Individual results vary based on practice type, specialty, and patient volume.
Pricing Comparison
Suki
Enterprise pricing (contact sales)
Contact for pricing
Scribeable offers transparent pricing accessible to all practitioners — no enterprise contract required
Which Should You Choose?
Choose Suki if you...
- Users who want voice-command EHR navigation features
- Organizations with existing Suki enterprise agreements
- Practices needing in-EHR voice control beyond documentation
Frequently Asked Questions
Compare Other Alternatives
vs Nuance DAX
Scribeable delivers superior note quality at 50-75% less cost. Built by clinicians who understand documentation pain points, with faster setup and no enterprise complexity.
vs Nabla
Scribeable offers superior note quality, more features, and better pricing — all built by clinicians who understand documentation needs. More note types, better billing, and lower cost.
vs Abridge
Scribeable delivers superior note quality built by clinicians, with more specialty support, comprehensive billing features, and transparent pricing accessible to all practitioners.
Try Scribeable Free — 15 Notes, No Credit Card
See why physicians switch from Suki. Generate your first note in under 5 minutes.
Scribeable vs Suki - AI Medical Scribe Comparison
Scribeable offers superior ambient documentation with comprehensive billing optimization, transparent pricing, and seamless web + mobile access — all built by clinicians.
Why Physicians Switch from Suki
- Voice-command paradigm requires memorizing commands — not true ambient listening
- Enterprise pricing with no published rates or self-service signup
- Limited note type variety compared to full ambient scribe solutions
Why Choose Scribeable Over Suki
- Superior ambient documentation — not just voice commands
- Comprehensive billing (ICD-10, HCC, E&M optimization)
- Transparent pricing without enterprise contracts
- Native iOS app with Apple Watch support
- Free tier with 15 notes/month
- Faster setup with no implementation required
- Unique Rounding Mode: record an entire round, get all notes at once — no competitor has this
Ambient Listening vs. Voice Commands
Suki started as a voice assistant — you speak commands to fill in note fields. While they've added ambient features, the core paradigm is different from Scribeable's fully ambient approach. With Scribeable, you simply have a natural conversation with your patient and a complete note appears. No commands to memorize, no structured dictation, no workflow interruption. True ambient documentation means you focus on the patient, not the software.
Billing Intelligence Built In
Suki focuses on documentation speed, but leaves revenue on the table. Scribeable analyzes every encounter for ICD-10 codes, HCC/RAF opportunities, and appropriate E&M levels. Physicians who switch from Suki consistently find they were under-coding visits — missing $30-50 per encounter that adds up to tens of thousands annually. Documentation should pay for itself.
Accessible to Every Practice Size
Suki's enterprise model means custom pricing, sales conversations, and procurement processes. Scribeable publishes every price, offers a free tier with 15 notes per month, and lets you upgrade to Pro at $89/month with a single tap. Whether you're a solo family physician or a 50-provider group, you get the same powerful tool at the same published price.
Rounding Mode: A Feature No Other Scribe Offers
Hospitalists and rounding physicians see the most patients per day — and they're exactly the users who need multi-patient documentation the most. Scribeable's Rounding Mode lets you record an entire round in one session and generates individual notes for every patient. Suki requires you to start and stop for each encounter. For physicians who round daily, this single feature can save 30+ minutes and eliminate the documentation backlog that builds up by afternoon.
Feature Comparison: Scribeable vs Suki
Documentation
| Feature | Scribeable | Suki |
|---|---|---|
| Ambient recording | Yes | Yes |
| Voice commands | Partial | Yes |
| AI note generation | Yes | Yes |
| Multiple note types | Yes | Partial |
| Multi-patient rounding mode | Yes | No |
EHR Integration
| Feature | Scribeable | Suki |
|---|---|---|
| Epic integration | Yes | Yes |
| Cerner integration | Yes | Yes |
| EHR navigation | No | Yes |
| Browser extension | Yes | Partial |
Billing
| Feature | Scribeable | Suki |
|---|---|---|
| ICD-10 suggestions | Yes | Partial |
| HCC code capture | Yes | No |
| E&M optimization | Yes | Partial |
Access
| Feature | Scribeable | Suki |
|---|---|---|
| Free tier | Yes | No |
| Solo practitioner plans | Yes | Partial |
| Transparent pricing | Yes | No |
Pricing Comparison
Scribeable: Free, then $89-149/month
Suki: Enterprise pricing (contact sales)
Scribeable offers transparent pricing accessible to all practitioners — no enterprise contract required
What Physicians Say
I used Suki for a year but always felt like I was dictating to a computer. Scribeable lets me just talk to my patients naturally. The notes are better, and the billing codes caught things I was missing every day.
Dr. L. Chen, Primary Care, Community Health Center
Which Should You Choose?
Choose Scribeable for superior ambient documentation, comprehensive billing optimization, and transparent pricing. Choose Suki if you need voice-command EHR navigation and have enterprise IT support.
Frequently Asked Questions
What's the difference between Suki's voice assistant and Scribeable's ambient scribe?
Suki uses a command-based paradigm — you speak structured commands to create notes and navigate your EHR. Scribeable uses fully ambient listening — you have a natural conversation with your patient and a complete note is generated automatically. No commands, no structured dictation.
Does Suki offer EHR features that Scribeable doesn't?
Yes. Suki includes voice-command EHR navigation (ordering labs, navigating charts by voice). Scribeable focuses on ambient documentation and billing optimization. If voice EHR navigation is critical to your workflow, Suki has an edge there.
How much does Suki cost compared to Scribeable?
Suki does not publish pricing and requires an enterprise sales process. Scribeable pricing is transparent: free for 15 notes/month, $89/month for Pro, $149/month for Elite. No contracts, no sales calls required.
Can I switch from Suki to Scribeable easily?
Yes. Scribeable requires no implementation or IT involvement. Download the app, sign up for free, and generate your first note in minutes. You can run both tools in parallel during your transition.
Explore More
Discover how Scribeable can help your practice with AI-powered clinical documentation